491 related articles for article (PubMed ID: 33503974)
21. Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson's Disease.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Cells; 2020 Jan; 9(2):. PubMed ID: 32012898
[TBL] [Abstract][Full Text] [Related]
22. Lithium stimulates human bone marrow derived mesenchymal stem cell proliferation through GSK-3β-dependent β-catenin/Wnt pathway activation.
Zhu Z; Yin J; Guan J; Hu B; Niu X; Jin D; Wang Y; Zhang C
FEBS J; 2014 Dec; 281(23):5371-89. PubMed ID: 25265417
[TBL] [Abstract][Full Text] [Related]
23. Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction.
Zhang L; Cen L; Qu S; Wei L; Mo M; Feng J; Sun C; Xiao Y; Luo Q; Li S; Yang X; Xu P
PLoS One; 2016; 11(4):e0152931. PubMed ID: 27045591
[TBL] [Abstract][Full Text] [Related]
24. Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.
Vallée A; Lecarpentier Y
Front Immunol; 2018; 9():745. PubMed ID: 29706964
[TBL] [Abstract][Full Text] [Related]
25. "Reframing" dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2/Wnt driver: Therapeutical implications.
Marchetti B; Giachino C; Tirolo C; Serapide MF
Aging Cell; 2022 Apr; 21(4):e13575. PubMed ID: 35262262
[TBL] [Abstract][Full Text] [Related]
26. Dopamine D1 receptor activation improves adult hippocampal neurogenesis and exerts anxiolytic and antidepressant-like effect via activation of Wnt/β-catenin pathways in rat model of Parkinson's disease.
Mishra A; Singh S; Tiwari V; Parul ; Shukla S
Neurochem Int; 2019 Jan; 122():170-186. PubMed ID: 30500462
[TBL] [Abstract][Full Text] [Related]
27. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.
Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D
Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519
[TBL] [Abstract][Full Text] [Related]
28. Wnt/β-catenin signaling is required to rescue midbrain dopaminergic progenitors and promote neurorepair in ageing mouse model of Parkinson's disease.
L'Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Serapide MF; Pluchino S; Marchetti B
Stem Cells; 2014 Aug; 32(8):2147-63. PubMed ID: 24648001
[TBL] [Abstract][Full Text] [Related]
29. Effects of lithium on cytokine neuro-inflammatory mediators, Wnt/β-catenin signaling and microglial activation in the hippocampus of chronic mild stress-exposed rats.
Habib MZ; Ebeid MA; El Faramawy Y; Saad SST; El Magdoub HM; Attia AA; Aboul-Fotouh S; Abdel-Tawab AM
Toxicol Appl Pharmacol; 2020 Jul; 399():115073. PubMed ID: 32454056
[TBL] [Abstract][Full Text] [Related]
30. Neurodegeneration and inflammation in Parkinson's disease.
Phani S; Loike JD; Przedborski S
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S207-9. PubMed ID: 22166436
[TBL] [Abstract][Full Text] [Related]
31. L-Theanine alleviates MPTP-induced Parkinson's disease by targeting Wnt/β-catenin signaling mediated by the MAPK signaling pathway.
Ratih K; Lee YR; Chung KH; Song DH; Lee KJ; Kim DH; An JH
Int J Biol Macromol; 2023 Jan; 226():90-101. PubMed ID: 36502788
[TBL] [Abstract][Full Text] [Related]
32. Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease.
Trist BG; Hare DJ; Double KL
Aging Cell; 2019 Dec; 18(6):e13031. PubMed ID: 31432604
[TBL] [Abstract][Full Text] [Related]
33. Lithium fails to protect dopaminergic neurons in the 6-OHDA model of Parkinson's disease.
Yong Y; Ding H; Fan Z; Luo J; Ke ZJ
Neurochem Res; 2011 Mar; 36(3):367-74. PubMed ID: 21203835
[TBL] [Abstract][Full Text] [Related]
34. Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Neuromolecular Med; 2018 Jun; 20(2):174-204. PubMed ID: 29572723
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the canonical Wnt pathway by Dickkopf-1 contributes to the neurodegeneration in 6-OHDA-lesioned rats.
Dun Y; Li G; Yang Y; Xiong Z; Feng M; Wang M; Zhang Y; Xiang J; Ma R
Neurosci Lett; 2012 Sep; 525(2):83-8. PubMed ID: 22902902
[TBL] [Abstract][Full Text] [Related]
36. LncRNA H19 diminishes dopaminergic neuron loss by mediating microRNA-301b-3p in Parkinson's disease via the HPRT1-mediated Wnt/β-catenin signaling pathway.
Jiang J; Piao X; Hu S; Gao J; Bao M
Aging (Albany NY); 2020 May; 12(10):8820-8836. PubMed ID: 32434961
[TBL] [Abstract][Full Text] [Related]
37. LGK974, a PORCUPINE inhibitor, mitigates cytotoxicity in an in vitro model of Parkinson's disease by interfering with the WNT/β-CATENIN pathway.
Yang JM; Huang HM; Cheng JJ; Huang CL; Lee YC; Chiou CT; Huang HT; Huang NK; Yang YC
Toxicology; 2018 Dec; 410():65-72. PubMed ID: 30205152
[TBL] [Abstract][Full Text] [Related]
38. Circadian Rhythms and Energy Metabolism Reprogramming in Parkinson's Disease.
Vallée A; Lecarpentier Y; Vallée JN
Curr Issues Mol Biol; 2019; 31():21-44. PubMed ID: 31160540
[TBL] [Abstract][Full Text] [Related]
39. Riluzole: a therapeutic strategy in Alzheimer's disease by targeting the WNT/β-catenin pathway.
Vallée A; Vallée JN; Guillevin R; Lecarpentier Y
Aging (Albany NY); 2020 Feb; 12(3):3095-3113. PubMed ID: 32035419
[TBL] [Abstract][Full Text] [Related]
40. Axin-2 knockdown promote mitochondrial biogenesis and dopaminergic neurogenesis by regulating Wnt/β-catenin signaling in rat model of Parkinson's disease.
Singh S; Mishra A; Mohanbhai SJ; Tiwari V; Chaturvedi RK; Khurana S; Shukla S
Free Radic Biol Med; 2018 Dec; 129():73-87. PubMed ID: 30176346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
